Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Peter Clark, MA, MD, FRCP: A Payer Perspective

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement




Jul
26
Today In Oncology
Does Bilateral Mastectomy for Unilateral Breast Cancer Impact Mortality
Patients With Prostate Cancer Social Factors May Be Tied to Racial Disparities in Cardiovascular Outcomes
Update on LEANer Trial in Patients With Breast Cancer
Triplet as Initial Salvage Treatment for Advanced Germ Cell Tumors Long-Term Outcomes
New Study Highlights Improvements in Treating Pediatric Patients With Retinoblastoma
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Conexiant Oncology Logo